Breast Cancer Research and Treatment View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1981

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10549

Recent publications latest 20 shown

  • 2019-04-12 Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
  • 2019-04-12 The association between mammographic density and breast cancer risk in Western Australian Aboriginal women.
  • 2019-04-12 Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review.
  • 2019-04-11 Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy.
  • 2019-04-11 Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
  • 2019-04-11 Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
  • 2019-04-10 Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
  • 2019-04-10 Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
  • 2019-04-06 Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
  • 2019-04-06 Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women.
  • 2019-04-06 Effects of physical and mind-body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis.
  • 2019-04-05 Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm.
  • 2019-04-04 Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
  • 2019-04-04 GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.
  • 2019-04-02 Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer
  • 2019-04-02 Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
  • 2019-04 Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
  • 2019-04 A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
  • 2019-04-01 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion
  • 2019-04 The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.208", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "2.066", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.605", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "3.626", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "4.085", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.940", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "4.198", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.859", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "4.696", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "4.469", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "4.431", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "5.684", 
            "type": "Rating"
          }
        ], 
        "description": "

    Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a \"market place\" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

    Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need.

    Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.

    ", "editor": [ { "familyName": "Lippman", "givenName": "Marc", "type": "Person" } ], "id": "sg:journal.1092777", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0167-6806", "1573-7217" ], "license": "Hybrid (Open Choice)", "name": "Breast Cancer Research and Treatment", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "28766" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0167-6806/BREAST CANCER RESEARCH AND TREATMENT" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8111104" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "342632" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "10549" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 82002391" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "92777" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "15824" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "1981", "type": "Periodical", "url": "http://link.springer.com/journal/10549" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1092777'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1092777'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1092777'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1092777'


     

    This table displays all metadata directly associated to this object as RDF triples.

    146 TRIPLES      21 PREDICATES      41 URIs      36 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1092777 schema:about sg:ontologies/product-market-codes/H33160
    2 schema:contentRating N01a824c136d945bd8e8356107661d94a
    3 N02da3ffe3d84477bb72f8f0046ec250f
    4 N15e82eb043c6403ba9e868180e8bc088
    5 N2020dd2181a743148d0ac6bed16fbec6
    6 N2c9436112aaa44d692abb5249707ef93
    7 N2d45fe3462954e69bbddb322cc714f3f
    8 N2db8e06adc8d4ac698bee049a9f92a91
    9 N388c50d272aa49319915d3d3ffbf2a24
    10 N405266ac2ab14c29909dd60cdb5ac4ca
    11 N8667442aa38b44a0a5a3945b3872b3ab
    12 Na7e7cb1c7d8a4bdd8c81a0739bf7a2ac
    13 Ne5c1d9c6602b4f4384758937b277d97b
    14 schema:description <p><i>Breast Cancer Research and Treatment</i> provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.<br/><br/>Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. <i>Breast Cancer Research and</i> <i>Treatment</i> aims to fill this need.<br/><br/>Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer. </p>
    15 schema:editor Nca861cd987744e3793759f34a6177258
    16 schema:inLanguage en
    17 schema:isAccessibleForFree false
    18 schema:issn 0167-6806
    19 1573-7217
    20 schema:license Hybrid (Open Choice)
    21 schema:name Breast Cancer Research and Treatment
    22 schema:productId N12ba7ae5df2e4a168812cd239dd0bd51
    23 N58d6f8ee1d4a4cc0b523bb67bffe8b43
    24 N989b6a1b920146dab7081d1aa8e60012
    25 Nbce4a7e08c134e029db99e2b42af9349
    26 Nc6ea6fe092f14301b6e0c1c1f690eb55
    27 Nd2a4374252964890802fd4d5ba85e06a
    28 Nde94c143744347a9b5f82c9917c544f7
    29 Nfd2619b95ce246439a5c36f95dede42e
    30 schema:publisher N540cfe6b380c469b935bedae4e7465de
    31 schema:publisherImprint Springer
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777
    33 schema:sdDatePublished 2019-03-18T11:05
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher N7a54d2f589564e62a75d245a9cc73361
    36 schema:startYear 1981
    37 schema:url http://link.springer.com/journal/10549
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset journals
    40 rdf:type schema:Periodical
    41 N01a824c136d945bd8e8356107661d94a schema:author N592aaba69d50454e9431e96ef3011d46
    42 schema:dateCreated 2011
    43 schema:ratingValue 4.431
    44 rdf:type schema:Rating
    45 N02da3ffe3d84477bb72f8f0046ec250f schema:author N8cbc0c43c65f4817a50ed5484fefad1a
    46 schema:ratingValue 1.208
    47 rdf:type schema:Rating
    48 N04e79890323a416aa67a13e413dc4dd9 rdf:first impact_factor_wos
    49 rdf:rest rdf:nil
    50 N12ba7ae5df2e4a168812cd239dd0bd51 schema:name springer_id
    51 schema:value 10549
    52 rdf:type schema:PropertyValue
    53 N15e82eb043c6403ba9e868180e8bc088 schema:author N04e79890323a416aa67a13e413dc4dd9
    54 schema:dateCreated 2008
    55 schema:ratingValue 5.684
    56 rdf:type schema:Rating
    57 N2020dd2181a743148d0ac6bed16fbec6 schema:author N687712c5851c464c8257c0b56cdcd6a7
    58 schema:dateCreated 2012
    59 schema:ratingValue 4.469
    60 rdf:type schema:Rating
    61 N2c9436112aaa44d692abb5249707ef93 schema:author N8457dcac7d094bf7ac0a8c78137c38f0
    62 schema:dateCreated 2016
    63 schema:ratingValue 3.626
    64 rdf:type schema:Rating
    65 N2d45fe3462954e69bbddb322cc714f3f schema:author N3aee4925e1b841d790637b745032f7ee
    66 schema:dateCreated 2014
    67 schema:ratingValue 3.940
    68 rdf:type schema:Rating
    69 N2db8e06adc8d4ac698bee049a9f92a91 schema:author N894d2e4a884249f6ad1a0757ee862bfd
    70 schema:ratingValue 2.066
    71 rdf:type schema:Rating
    72 N388c50d272aa49319915d3d3ffbf2a24 schema:author Nc38228b02b1d464793005017075f6dab
    73 schema:dateCreated 2015
    74 schema:ratingValue 4.085
    75 rdf:type schema:Rating
    76 N3aee4925e1b841d790637b745032f7ee rdf:first impact_factor_wos
    77 rdf:rest rdf:nil
    78 N405266ac2ab14c29909dd60cdb5ac4ca schema:author N75f765d346d54bd3b774e4ea8d0a3bf2
    79 schema:dateCreated 2009
    80 schema:ratingValue 4.696
    81 rdf:type schema:Rating
    82 N540cfe6b380c469b935bedae4e7465de schema:name Springer US
    83 rdf:type schema:Organization
    84 N58d6f8ee1d4a4cc0b523bb67bffe8b43 schema:name dimensions_id
    85 schema:value 92777
    86 rdf:type schema:PropertyValue
    87 N592aaba69d50454e9431e96ef3011d46 rdf:first impact_factor_wos
    88 rdf:rest rdf:nil
    89 N687712c5851c464c8257c0b56cdcd6a7 rdf:first impact_factor_wos
    90 rdf:rest rdf:nil
    91 N6914abab21d2445a9559d6712b78ffcc rdf:first impact_factor_wos
    92 rdf:rest rdf:nil
    93 N75f765d346d54bd3b774e4ea8d0a3bf2 rdf:first impact_factor_wos
    94 rdf:rest rdf:nil
    95 N78b6f6846afb48758389be4f014e1498 schema:familyName Lippman
    96 schema:givenName Marc
    97 rdf:type schema:Person
    98 N7a54d2f589564e62a75d245a9cc73361 schema:name Springer Nature - SN SciGraph project
    99 rdf:type schema:Organization
    100 N8457dcac7d094bf7ac0a8c78137c38f0 rdf:first impact_factor_wos
    101 rdf:rest rdf:nil
    102 N8667442aa38b44a0a5a3945b3872b3ab schema:author N6914abab21d2445a9559d6712b78ffcc
    103 schema:dateCreated 2010
    104 schema:ratingValue 4.859
    105 rdf:type schema:Rating
    106 N894d2e4a884249f6ad1a0757ee862bfd rdf:first sjr
    107 rdf:rest rdf:nil
    108 N8cbc0c43c65f4817a50ed5484fefad1a rdf:first snip
    109 rdf:rest rdf:nil
    110 N989b6a1b920146dab7081d1aa8e60012 schema:name nlm_unique_id
    111 schema:value 8111104
    112 rdf:type schema:PropertyValue
    113 Na7e7cb1c7d8a4bdd8c81a0739bf7a2ac schema:author Nd97368d45a004dd597f3bc1b87fd37c2
    114 schema:dateCreated 2017
    115 schema:ratingValue 3.605
    116 rdf:type schema:Rating
    117 Nbce4a7e08c134e029db99e2b42af9349 schema:name lccn_id
    118 schema:value sn 82002391
    119 rdf:type schema:PropertyValue
    120 Nc38228b02b1d464793005017075f6dab rdf:first impact_factor_wos
    121 rdf:rest rdf:nil
    122 Nc6ea6fe092f14301b6e0c1c1f690eb55 schema:name era_ids_id
    123 schema:value 15824
    124 rdf:type schema:PropertyValue
    125 Nca861cd987744e3793759f34a6177258 rdf:first N78b6f6846afb48758389be4f014e1498
    126 rdf:rest rdf:nil
    127 Nd2a4374252964890802fd4d5ba85e06a schema:name nsd_ids_id
    128 schema:value 342632
    129 rdf:type schema:PropertyValue
    130 Nd97368d45a004dd597f3bc1b87fd37c2 rdf:first impact_factor_wos
    131 rdf:rest rdf:nil
    132 Nde94c143744347a9b5f82c9917c544f7 schema:name scopus_id
    133 schema:value 28766
    134 rdf:type schema:PropertyValue
    135 Ne5c1d9c6602b4f4384758937b277d97b schema:author Ned746a6c006c4eeda68b89ecf075ab58
    136 schema:dateCreated 2013
    137 schema:ratingValue 4.198
    138 rdf:type schema:Rating
    139 Ned746a6c006c4eeda68b89ecf075ab58 rdf:first impact_factor_wos
    140 rdf:rest rdf:nil
    141 Nfd2619b95ce246439a5c36f95dede42e schema:name wos_id
    142 schema:value 0167-6806/BREAST CANCER RESEARCH AND TREATMENT
    143 rdf:type schema:PropertyValue
    144 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    145 schema:name Oncology
    146 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...